SINGAPORE GENERAL HOSPITAL
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 1821-01-01
- Employees
- -
- Market Cap
- -
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) Program
Not Applicable
Completed
- Conditions
- Pre-diabetes
- Interventions
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 751
- Registration Number
- NCT03503942
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Impact of Preoperative Anemia on Healthcare Outcomes
- Conditions
- Anemia
- Interventions
- Other: No intervention
- First Posted Date
- 2018-04-13
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 450
- Registration Number
- NCT03497416
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms
Not Applicable
- Conditions
- Pancreatic NeoplasmsPancreatic Neuroendocrine TumorPancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma
- Interventions
- Device: EUSRA RFA needle
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03435770
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis
Not Applicable
Active, not recruiting
- Conditions
- Axial Spondyloarthritis
- Interventions
- Other: TCM physician involved collaborative care model (TCMCMC)
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT03420404
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients
Not Applicable
Completed
- Conditions
- Peritoneal Dialysis Catheter Exit Site Infection
- Interventions
- Device: Chlorhexidine-impregnated disk
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03406520
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Comparing Proposed Algorithm and Current Practice in the Evaluation of Suspected Appendicitis
Not Applicable
- Conditions
- Acute Appendicitis
- Interventions
- Other: Proposed Algorithm
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT03324165
- Locations
- 🇸🇬
Sengkang Health, Singapore, Singapore
🇸🇬Singapore General Hospital, Singapore, Singapore
Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial
Phase 4
- Conditions
- AnemiaPre-operativeMajor Abdominal Surgery
- Interventions
- First Posted Date
- 2017-09-28
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03295851
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Protocol for Observational Study of Post op Delirium Following Total Joint Arthroplasties
- Conditions
- Postoperative Delirium
- First Posted Date
- 2017-08-24
- Last Posted Date
- 2017-08-31
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT03260218
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease Patients
Not Applicable
- Conditions
- HypertensionChronic Kidney DiseasesCardiovascular Diseases
- Interventions
- Device: Active autoRIC® (CRIC Treatment)Device: Sham Control autoRIC® (Sham Control)
- First Posted Date
- 2017-08-01
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 85
- Registration Number
- NCT03236350
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
Phase 2
Withdrawn
- Conditions
- EBV Related Non-Hodgkin's LymphomaPrimary CNS LymphomaPrimary Testicular Lymphoma
- Interventions
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- Singapore General Hospital
- Registration Number
- NCT03212807
- Locations
- 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬Raffles Hospital, Singapore, Singapore
🇸🇬Singapore General Hospital, Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath